These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35297648)
41. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
42. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer. Vogel TJ; Goodman MT; Li AJ; Jeon CY Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017 [TBL] [Abstract][Full Text] [Related]
43. Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study. Thacker EL; Muntner P; Zhao H; Safford MM; Curtis JR; Delzell E; Bittner V; Brown TM; Levitan EB BMC Health Serv Res; 2014 Apr; 14():195. PubMed ID: 24779477 [TBL] [Abstract][Full Text] [Related]
44. Development of a Machine Learning Model to Identify Colorectal Cancer Stage in Medicare Claims. Finn CB; Sharpe JE; Tong JK; Kaufman EJ; Wachtel H; Aarons CB; Weissman GE; Kelz RR JCO Clin Cancer Inform; 2023 May; 7():e2300003. PubMed ID: 37257142 [TBL] [Abstract][Full Text] [Related]
45. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer. Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649 [TBL] [Abstract][Full Text] [Related]
46. Underreporting of myeloid malignancies by United States cancer registries. Craig BM; Rollison DE; List AF; Cogle CR Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):474-81. PubMed ID: 22237987 [TBL] [Abstract][Full Text] [Related]
47. Validation of an Algorithm for Claims-based Incidence of Prostate Cancer. Parlett LE; Beachler DC; Lanes S; Hoover RN; Cook MB Epidemiology; 2019 May; 30(3):466-471. PubMed ID: 30829831 [TBL] [Abstract][Full Text] [Related]
48. Validation of claims-based algorithms for psoriatic arthritis. Lee H; Ford JA; Jin Y; Cho SK; Santiago Ortiz AJ; Tong AY; Kim SC Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):404-408. PubMed ID: 31849154 [TBL] [Abstract][Full Text] [Related]
49. Accuracy of Medicare Claim-based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases. Sathiakumar N; Delzell E; Yun H; Jooste R; Godby K; Falkson C; Yong M; Kilgore ML Med Care; 2017 Dec; 55(12):e144-e149. PubMed ID: 29135778 [TBL] [Abstract][Full Text] [Related]
50. Use of SEER-Medicare data for measuring cancer surgery. Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167 [TBL] [Abstract][Full Text] [Related]
51. Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry. Howlader N; Ward KC; Warren JL; Campbell DS; Coyle L; Mariotto AB J Natl Cancer Inst Monogr; 2020 May; 2020(55):82-88. PubMed ID: 32412070 [TBL] [Abstract][Full Text] [Related]
52. The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw. Wright NC; Curtis JR; Arora T; Smith WK; Kilgore ML; Saag KG; Safford MM; Delzell ES PLoS One; 2015; 10(7):e0131601. PubMed ID: 26161858 [TBL] [Abstract][Full Text] [Related]
53. Racial and socioeconomic disparities in adherence to preventive health services for ovarian cancer survivors. Loomer L; Ward KC; Reynolds EA; von Esenwein SA; Lipscomb J J Cancer Surviv; 2019 Aug; 13(4):512-522. PubMed ID: 31172430 [TBL] [Abstract][Full Text] [Related]
54. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355 [TBL] [Abstract][Full Text] [Related]
55. Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States. Huepenbecker SP; Sun CC; Fu S; Zhao H; He W; Primm K; Giordano SH; Meyer LA Int J Gynecol Cancer; 2022 Jul; 32(7):899-905. PubMed ID: 35331992 [TBL] [Abstract][Full Text] [Related]
56. Pre-diagnosis health-related quality of life, surgery, and survival in women with advanced epithelial ovarian cancer: A SEER-MHOS study. Doll KM; Pinheiro LC; Reeve BB Gynecol Oncol; 2017 Feb; 144(2):348-353. PubMed ID: 27988047 [TBL] [Abstract][Full Text] [Related]
57. Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008-2010. Lai SM; Jungk J; Garimella S Prev Chronic Dis; 2015 Jul; 12():E107. PubMed ID: 26160293 [TBL] [Abstract][Full Text] [Related]
58. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database. Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193 [TBL] [Abstract][Full Text] [Related]
59. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data. Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW Am J Manag Care; 2004 Apr; 10(4):257-62. PubMed ID: 15124502 [TBL] [Abstract][Full Text] [Related]
60. A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer. Beachler DC; Lamy FX; Russo L; Taylor DH; Dinh J; Yin R; Jamal-Allial A; Dychter S; Lanes S; Verpillat P J Ovarian Res; 2020 Aug; 13(1):101. PubMed ID: 32867806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]